WISP2 anticorps (AA 87-116)

N° du produit ABIN7877011

Cet anticorps anti-WISP2 Polyclonal Lapin (ABIN7877011) détecte spécifiquement WISP2 dans WB et IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour WISP2 anticorps (AA 87-116) (ABIN7877011)

Antigène: WISP2 (WNT1 Inducible Signaling Pathway Protein 2 (WISP2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp WISP2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-WISP2 anticorps

Épitope: AA 87-116

Fonction: WISP-2 Antibody / WNT1-inducible-signaling pathway protein 2 / CCN5

Immunogène: A portion of amino acids 87-116 from the human protein was used as the immunogen for this WISP-2 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Titration of the WISP-2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the WISP-2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur WISP2

Antigène: WISP2 (WNT1 Inducible Signaling Pathway Protein 2 (WISP2))

Autre désignation: WISP-2

Sujet: CCN5, also known as WISP-2 (Wnt-1-induced secreted protein 2), is a member of the CCN family of proteins that are involved in cell growth, differentiation, and migration. It is known for its ability to modulate signaling pathways that regulate various cellular activities, making it a key player in maintaining homeostasis in tissues. One of the primary functions of CCN5 is its role in regulating the growth and development of tissues, particularly in the cardiovascular system. Studies have shown that CCN5 can protect against cardiac fibrosis and hypertrophy, making it a potential therapeutic target for heart-related diseases. Furthermore, CCN5 has been found to have anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory conditions. Its ability to regulate immune responses and modulate cytokine production highlights its potential as a target for managing inflammatory disorders. CCN5 has also been implicated in the regulation of metabolic processes and energy homeostasis. Research has shown that CCN5 can influence lipid metabolism and insulin sensitivity, suggesting its potential use in combating metabolic disorders such as obesity and diabetes.

UniProt: O76076

Pathways: Signalisation WNT, Growth Factor Binding